Cyriax Inferior Capsule Stretching in Idiopathic Adhesive Capsulitis

Adhesive Capsulitis Clinical Trial

Official title:

Effect of Cyriax Inferior Capsule Stretching in Idiopathic Adhesive Capsulitis

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04157387
• Other study ID #: RiphahIU Ramsha Tariq
• Status: Completed
• Phase: N/A
• Start date: January 1, 2018
• Est. completion date: June 30, 2018

Study information

• Verified date: January 2020
• Source: Riphah International University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The objective of study is to find out the effectiveness of cyriax capsular stretching in idiopathic adhesive capsulitis and to find out the combined effect of capsular stretching's, mobilization and conservative treatment on pain and Range of Motion (ROM) in idiopathic adhesive capsulitis.

Description:

This Randomized study was carried out at Pakistan Railway Hospital Rawalpindi. A total of 28 patients were screened out as per inclusion criteria and randomly placed into two groups A and B through lottery method. The Visual Analogue scale, Shoulder Pain and Disability Index, and Range of Motion of shoulder joint were used as outcome measures. All the patients were assessed at baseline before intervention and at the completion of 3weeks of treatment.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 28
• Est. completion date: June 30, 2018
• Est. primary completion date: June 30, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 30 Years to 70 Years

Eligibility

Inclusion Criteria:

• Idiopathic Adhesive capsulitis phase 1 and phase 2

• Follow capsular pattern ( ER > Abduction> IR)

Exclusion Criteria:

• Adhesive capsulitis phase 3

• Any intrinsic etiology i.e. rheumatoid arthritis,

• infection,

• gout,

• haemarthrosis or

• tumor or Arthritis in stage III or in stage II with a spastic end-feel

Related Conditions & MeSH terms

• Adhesive Capsulitis
• Bursitis

Intervention

Other:
• Cyriax inferior capsular stretching + Manual Therapy
Electro-therapy 10mins Manual therapy : Kalternbon grade 1 and 2 Mobilization : Inferior glide (10x3), posterior glide, (10 reps x 3 sets), anterior glide (10 reps x 3 sets), Active ROM exercises : 10 reps x 3 sets Home plan include :, wall walking exercises, pendulum exercises ,towel stretch exercises, Cross Body Adduction (10reps x 2 sets ,each) Cyriax inferior capsular stretching
• Manual therapy
Before starting capsule stretching technique, Analgesic short-wave diathermy may be given for 10 minutes. Kalternbon grade 1 and 2 Mobilization : Inferior glide (10x3), posterior glide, (10 reps x 3 sets), anterior glide (10 reps x 3 sets), Home plan include :, wall walking exercises, pendulum exercises ,towel stretch exercises, Cross Body Adduction (10reps x 2 sets ,each)

Locations

Country	Name	City	State
Pakistan	Riphah International university	Rawalpindi	Punjab

Sponsors (1)

Lead Sponsor	Collaborator
Riphah International University

Country where clinical trial is conducted

Pakistan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Goniometer	Changes from the baseline, Measure the available range of motion or the position of the shoulder joint - typically this is a measure of passive motion like External Rotation, External Rotation and Internal Rotation.	3rd week
Primary	Visual Analogue Scale (VAS)	Changes from the baseline, Normative values are not presented so by using a ruler , the score is calculated by measure the distance on 10cm line between the "no pain" point and the patient's mark, provide a range of score from 0-100. A higher score indicates greater pain intensity.	3rd Week
Primary	Shoulder pain and disability index (SPADI)	Changes from the Baseline, SPADI is a self-administered questionnaire that aims to measure pain and disability associated with shoulder disease. It consists of two dimensions, one for pain and second for functional activities.; The pain element consists of five questions regarding severity of pain and to measure the degree of severity that an individual faced during various activities of daily life that involve upper extremity use. There are eight questions.; Each subscale is summed up and a total SPADI score is expressed as a percentage.Total pain score : --/50 ×100 = %, Total disability score: --/80 × 100 = %, Total SPADI score: --/130 × 100 = %.; A score of 0 indicates best 100 indicates worst. A higher score shows more disability.	3rd week